These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1561528)

  • 1. Faecal elastase reflects disease activity in active ulcerative colitis.
    Adeyemi EO; Hodgson HJ
    Scand J Gastroenterol; 1992; 27(2):139-42. PubMed ID: 1561528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PMN-elastase in assessment of patients with inflammatory bowel disease.
    Andus T; Gross V; Caesar I; Krumm D; Hosp J; Gerok W; Schölmerich J
    Dig Dis Sci; 1993 Sep; 38(9):1638-44. PubMed ID: 8359075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating human leucocyte elastase in patients with inflammatory bowel disease.
    Adeyemi EO; Neumann S; Chadwick VS; Hodgson HJ; Pepys MB
    Gut; 1985 Dec; 26(12):1306-11. PubMed ID: 3853525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
    Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
    Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase-1 status in Crohn's disease and ulcerative colitis.
    Boehm D; Krzystek-Korpacka M; Neubauer K; Matusiewicz M; Berdowska I; Zielinski B; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2009 Jan; 15(1):93-9. PubMed ID: 18626964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
    Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L
    Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
    Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
    J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
    Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
    Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's disease.
    Budzynska A; Gawron-Kiszka M; Nowakowska-Dulawa E; Spiewak J; Lesinska M; Kukla M; Waluga M; Hartleb M
    J Physiol Pharmacol; 2017 Dec; 68(6):859-865. PubMed ID: 29550798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The forms and the levels of fecal PMN-elastase in patients with colorectal diseases.
    Saitoh O; Sugi K; Matsuse R; Uchida K; Matsumoto H; Nakagawa K; Takada K; Yoshizumi M; Hirata I; Katsu K
    Am J Gastroenterol; 1995 Mar; 90(3):388-93. PubMed ID: 7872275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
    Aomatsu T; Imaeda H; Matsumoto K; Kimura E; Yoden A; Tamai H; Fujiyama Y; Mizoguchi E; Andoh A
    Aliment Pharmacol Ther; 2011 Oct; 34(8):941-8. PubMed ID: 21848856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 and granulocyte elastase in the evaluation of activity of inflammatory bowel disease. A pilot study.
    Ciećko-Michalska I; Wierzbicka-Tutka I; Szczepanek M; Fedak D; Jabłoński K; Cibor D; Mach T
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():66-72. PubMed ID: 24491897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.